Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma.
Kazandjian D, Dew A, Hill E, Ramirez EG, Morrison C, Mena E, Lindenberg L, Yuan C, Maric I, Wang HW, Calvo K, Dulau-Florea A, Roswarski J, Emanuel M, Braylan R, Turkbey B, Choyke P, Camphausen K, Stetler-Stevenson M, Steinberg SM, Figg WD, C Jones J.
Kazandjian D, et al. Among authors: turkbey b.
Oncologist. 2021 Apr;26(4):288-e541. doi: 10.1002/onco.13712. Epub 2021 Mar 10.
Oncologist. 2021.
PMID: 33554406
Free PMC article.
Clinical Trial.